Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Vector1 who wrote (5800)	10/23/1998 11:55:00 AM
From: Rocketman	Read Replies (1) \| Respond to of 9719

OK, this is the last AMLN trade. I know that Dead Cats are not the most tasteful way to make money, but they do tend to work well. We are not buying for the fundamentals here, we are taking advantage of the markets tendency to overreact and then bounce back towards the mean. It really isn't much different than Short Selling a great company like ICOS when it gets ahead of itself. You are just such an ethical guy though, I know it just galls you to support a loser company like this, so verbally I will make sure there is no misconception here: AMLN SUCKS, THEY COULDN'T DESIGN A CLINICAL STUDY RIGHT IF THEIR LIFE DEPENDED ON IT - AND IT DID, AND THEY ARE DEAD MEAT. Ahh, that felt good. Now, let's see that sucker bounce so we can double our money on it today or at least in the next week. I'm not sure if we can change the name of the thread. I'd have to email Jill the WebDominatrix and see if she can tweak the title for us. I'm sure I could shmooze her into it. I know she can do it because I had her fix the INCY thread mispelling of pharmaceutical a long time ago. How about Cyto? Do you like VD&C, VD&C's, VD&M, VD&M's, VDM's, VDM or ???? followed by Model Portfolio of course??? I don't want to change the VD letter combo as it works great in the search mode and is easy to tell newbies to go to SI and just search VD to find us. OK, let me make sure I have this derivative action right. By selling "covered" calls, we are betting that the share price does not continue to go up, but are locking in the profits on our existing shares because if it does keep going up we cover the calls with the shares we own, RIGHT??? Hmmm, I've been looking at AGPH wondering if we should take profits, so that goes with the gut. But, I also just did a quick look at there profile on Yahoo, and see that they have a market cap of $1.16B, trailing 12 month sales of $0.52B, a PE of 70 and $62M in cash. I'm not sure yet I want to bet against them continuing to go up. I want to dig a bit deeper in the financials and see how the revenue trend and future product potential looks. I think we continue to see the biotech boats rising and if that is the case, this is a boat that should be on top of the wave. Do you have info that makes you think that the product sales are unsustainable, or are you strictly thinking to lock in profits??? Also, what advantage is their to selling the covered calls versus just selling the shares outright? What calls at what price? How does this affect the marginability of the shares covering the calls? Also, if we do this, you are the one who has to coach CYTO through the bookkeeping if he needs help with it. Rman

To: Vector1 who wrote (5800)	10/23/1998 12:06:00 PM
From: scaram(o)uche	Read Replies (4) \| Respond to of 9719

>> They abused capital with poorly designed studies and achieved crappy results. There are numerous companies with great science and quality people who can't get funded. The AMLN's of the world are driving up the cost of capital. Kinda like insurance cheats driving up premiums. I am off my soap box for now. << Get back on it! Please repost every day. I once started a "Jeff Price Hall of Fame" that included luminaries like Roger of Calgene and the genius steering Cistron. Perhaps we should start a "pimple" list........ exchange2000.com